Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinoma.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinoma.
- Published In:
- Cancer letters, 563, 216192 (2023)
- Authors:
- Yang, Shih-Feng, Weng, Meng-Tzu, Liang, Ja-Der, Chiou, Ling-Ling, Hsu, Yu-Chen, Lee, Ying-Te, Liu, Shin-Yun, Wu, Meng-Chuan, Chou, Huei-Chi, Wang, Li-Fang, Yu, Shu-Han, Lee, Hsuan-Shu, Sheu, Jin-Chuan
- Database ID:
- RPEP-07584
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07584APA
Yang, Shih-Feng; Weng, Meng-Tzu; Liang, Ja-Der; Chiou, Ling-Ling; Hsu, Yu-Chen; Lee, Ying-Te; Liu, Shin-Yun; Wu, Meng-Chuan; Chou, Huei-Chi; Wang, Li-Fang; Yu, Shu-Han; Lee, Hsuan-Shu; Sheu, Jin-Chuan. (2023). Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinoma.. Cancer letters, 563, 216192. https://doi.org/10.1016/j.canlet.2023.216192
MLA
Yang, Shih-Feng, et al. "Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinoma.." Cancer letters, 2023. https://doi.org/10.1016/j.canlet.2023.216192
RethinkPeptides
RethinkPeptides Research Database. "Neoantigen vaccination augments antitumor effects of anti-PD..." RPEP-07584. Retrieved from https://rethinkpeptides.com/research/yang-2023-neoantigen-vaccination-augments-antitumor
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.